BlogHeader.png
Jjasmin D’Acunti

Jjasmin D’Acunti

Jjasmin D’Acunti has over 20 years of experience in the lifecycle of product development to ensure all products meet regulatory and compliance requirements for controlled substances in the pharmaceutical industry in the United States and Canada. Her controlled substances expertise spans across oral solids, parenteral, liquids, trans-dermal, sublingual, pre-formulation, formulation, analytical research & development, product development, generic, and branded. Jjasmin holds a Bachelor of Science degree in Business Administration from Berkeley College, a Master’s degree in Project Management from Keller Graduate School of Management of DeVry University, and is currently pursuing accreditation for supply chain management.

Recent Posts by Jjasmin D’Acunti:

Important Steps for Quota, Import, and Export Processes for DEA Controlled Substances

Controlled drug substances are scheduled based on medical use in treatment, potential for abuse, and dependence caused if abused— the lower the control schedule the more potential for abuse. The process to obtain approval from the Drug Enforcement Administration (DEA) for Schedule I-V controlled substances and List I chemicals licensing involves intricacy and a detailed timeline of approvals. This article will discuss the background of controlled substance applications and how to successfully work with the DEA.

Topics: Thought Leadership Regulatory Compliance API Drug Product Controlled Substances